Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Aug 1;176(2):133-6.
doi: 10.1016/0304-3940(94)90066-3.

Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression

Affiliations

Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression

W S Griffin et al. Neurosci Lett. .

Abstract

Activated microglia containing IL-1 alpha-immunoreactive (IL-1 alpha +) product were increased 3-fold in number in the acute phase following head injury, a risk factor for later development of Alzheimer's disease, and this increase was correlated with a 7-fold increase in the number of neurons with elevated beta-amyloid precursor protein (beta-APP) levels (R = 0.78; P < 0.05). Furthermore, clusters of beta-APP+ dystrophic neurites present in these patients were invariably associated with activated IL-1 alpha + microglia. These findings suggest that early overexpression of IL-1 alpha and beta-APP is a priming event for later neuropathological changes evident at end stages of Alzheimer's disease.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A: numbers (mean ± S.E.M.) of IL-1α+ microglia and β-APP+ neurons in mesial temporal lobe tissue sections from 7 head-injured and 6 control patients.*P < 0.05; **P < 0.01. B: correlation between numbers of activated IL-1α+ microglia and β-APP+ neurons in 7 head-injured patients (R = 0.78; P < 0.05).
Fig. 2
Fig. 2
β-APP+ (red) neurites and IL-1α+ (brown) microglia in dual-labeled immunohistochemically reacted tissue sections from mesial temporal lobe of control (A), head-injured (B), and Alzheimer's (C) patients. Bar = 15 μm.

References

    1. Brenneman DE, Schultzberg M, Bartfai T, Gozes I. Cytokine regulation of neuronal survival. J. Neurochem. 1992;58:454–460. - PubMed
    1. Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE, Greengard P. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer α/A4 amyloid protein precursor. Proc. Natl Acad. Sci. USA. 1992;89:10075–10078. - PMC - PubMed
    1. Clinton J, Ambler MW, Roberts GW. Post traumatic Alzheimer's disease: Predominance of a single plaque type, Neuropathol. Appl. Neurobiol. 1991;17:69–74. - PubMed
    1. da Cunha A, Jefferson JJ, Tyor WR, Glass JD, Jannotta FS, Vitkovic L. Gliosis in human brain: relationship to size but not other properties of astrocytes. Brain Res. 1993;600:161–165. - PubMed
    1. Dinarello CA, Wolff SM. The role of Interleukin-1 in disease. New Engl. J. Med. 1993;328:106–113. - PubMed

Publication types

Substances